Key references

1. Anesthetic Drug Interactions ASA03.pdf
   

2. Anesthetic potency is independent of forebrain structures.pdf
   

3. Are opioids indispensable for general anaesthesia Review 2019.pdf
   

4. Chronobiology and Anesthesia Review.pdf
   

5. Context sensitive Half life.pdf
   

6. Future of anaesthetic pharmacology IARS Review course 2007.pdf
   

7. Guidelines for the safe practice of total intravenous anaesthesia (TIVA) Review 2018.pdf

1. General Anesthesia, Sleep, and Coma Review.pdf
   

2. General anesthetic neurotoxicity IARS Review course 2007.pdf
   

3. Mechanisms of general anaesthetics IARS Review course 2007.pdf
   

4. Multimodal General Anesthesia Theory and Practice.pdf
   

5. Pharmaco economics IARS Review course 2002.pdf

1. Alpha 1 stimulants.pdf
   

2. Arginine Vasopressin Research Leading to New Therapeutic Strategies.pdf
   

3. Autonomic Nervous system pharmacology Miller.pdf
   

4. Miller Vasopressors.pdf

1. Codeine and opioid metabolism Review 2017.pdf
   

2. Direct effect of morphine on breast cancer cell function.pdf.pdf
   

3. Miller Opioids.pdf
   

4. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration Review 2014.pdf

1. Anaphylaxis Due to Propofol.pdf
   

2. Applied cardiovascular physiology in theatre measuring the cardiovascular effects of propofol anaesthesia.pdf
   

3. Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression.pdf
   

4. Efficacy of ketamine for initial control of acute agitation in the emergency department.pdf
   

5. Etomidate and General Anesthesia.pdf
   

6. Etomidate review.pdf
   

7. Etomidate vs ketamine for RSI + edit.pdf
   

8. Intranasal Ketamine Succeeds for Resistant Depression in Phase 3 Trial.pdf
   

9. Ketamine A Drug at War with Itself.pdf
   

1. Ketamine a growing global health-care need.pdf
   

2. Ketamine and staus epilepticus.pdf
   

3. Ketamine for acute suicidal ideation.pdf
   

4. Ketamine for Chronic Pain 2020.pdf
   

5. Ketamine Minus the Trip New Hope for Treatment-Resistant Depression.pdf
   

6. Lidocaine infusion as part of a balanced anaesthetic Review 2014.pdf
   

7. Miller IV Anaesthetic Agents.pdf
   

8. Off-Label Use of Ketamine as a Treatment for Mood Disorders.pdf
   

9. Perioperative Use of Intravenous Lidocaine Review 2017.pdf

1. ‣Non Opioid IV Anaesthetics

1. Inhalational Anesthetic Toxicity ASA06.pdf
   

2. Low Flow Sevoflurane.pdf
   

3. N20 and PONV.pdf
   

4. Nitrous oxide and serious long-term morbidity and mortality ENIGMA II.pdf
   

5. Nitrous oxide are we still in equipoise.pdf
   

6. N2O and surgical wound infection.pdf

1. Nitrous Oxide in Major Surgery Edit.pdf
   

2. Nitrous Oxide in Major Surgery Letters.pdf
   

3. Nitrous Oxide in Major Surgery.pdf
   

4. Nitrous oxide not associated with increased mortality.pdf
   

5. Severe Nausea and Vomiting in the Evaluation of Nitrous Oxide in the Gas Mixture for Anesthesia II Trial.pdf

1. ‣Opioids

1. ‣Autonomic Nervous System Pharmacology

1. Acceleromyographic versus Train of Four.pdf
   

2. Acceleromyography reduces residual NM Block.pdf
   

3. Acceleromyography Review.pdf
   

4. Anaphylaxis to neuromuscular blocking drugs.pdf
   

5. Anaphylaxis to Neuromuscular-blocking Drugs.pdf
   

6. Antagonising neuromuscular block at the end of surgery.pdf
   

7. Antagonism of Mivacurium Neuromuscular Block.pdf
   

8. Conceptual and technical insights into the basis of neuromuscular monitoring Review 2017.pdf
   

9. Corrugator supercilli.pdf
   

10. Current Status of Neuromuscular Reversal and Monitoring.pdf
    

11. dose related succinyl related myalgia .pdf
    

12. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade.pdf
    

13. Histamine release of NMBs.pdf
    

14. Impact of Hypothermia on the Response to Neuromuscular Blocking Drugs.pdf
    

15. Intraoperative Neuromuscular Monitoring Site and Residual Paralysis.pdf
    

16. Life-threatening hyperkalaemia after succinylcholine.pdf
    

1. Hemodynamic effects of methylene blue.pdf
   

2. MAOI and anaesthesia Review.pdf
   

3. Methylene blue hemodynamic changes.pdf
   

4. New treatments for Diabetes Anesthetic implications review.pdf
   

5. Nitric Oxide Story.pdf
   

6. Perioperative statins edit.pdf

1. Perioperative Statins Review.pdf
   

2. Perioperative statins review2.pdf
   

3. Perioperative statins review3.pdf
   

4. Platelet Glycoprotein IIb IIIa Antagonists review.pdf
   

5. Recent metformin does not increase perioperative morbidity or mortality.pdf

1. Miller Neuromuscular Blockers.pdf
   

2. Neostigmine but not edrophonium prolongs the action of mivacurium.pdf
   

3. Neuromuscular Blocking Agents-BARASH.pdf
   

4. Neuromuscular monitoring and postoperative residual curarization.pdf
   

5. Neuromuscular physiology and pharmacology 2012.pdf
   

6. New neuromuscular blocking agents review.pdf
   

7. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia.pdf
   

8. Prevention of succinylcholine myalgia review.pdf
   

9. Postoperative Residual Neuromuscular Blockade Is Associated with Impaired Clinical Recovery.pdf
   

10. Prolonged mivacurium block.pdf
    

11. Prolonged residual paralysis.pdf
    

12. Recovery from Neuromuscular Blockade.pdf
    

13. Recovery of Airway Protection after curarization.pdf
    

14. Relax for RSI IARS Review course 2006.pdf
    

15. Residual Neuromuscular Block Review.pdf
    

16. Residual NM Block Letters.pdf
    

17. Residual NM Blockade and critical events in PACU .pdf

1. Morphine-6-Glucuronide review.pdf
   

2. Opioid Pharmacology IARS Review course 2001.pdf
   

3. Opioids and Respiration Review.pdf
   

4. Oxycodone a review of its use in the management of pain.pdf
   

5. Pharmacokinetics, Pharmacodynamics, and Rational opioid selection.10.pdf

1. Residual Paralysis at the Time of Tracheal Extubation.pdf
   

2. Resistance to d_Tubocurarine of the Rat Diaphragm.pdf
   

3. Reversal of Neuromuscular Block by sugammadex.pdf
   

4. Reversal of neuromuscular block with sugammadex a comparison of the corrugator supercilii and adductor pollicis muscles.pdf
   

5. Reversal of mivacurium‐induced neuromuscular blockade with a cholinesterase inhibitor Review.pdf
   

6. Reversal with Sugammadex in the Absence of Monitoring Did Not Preclude Residual Neuromuscular Block.pdf
   

7. Rocuronium versus Suxamethonium.pdf
   

8. Sugammadex  An Update 2016.pdf
   

9. Sugammadex Provides Faster Reversal of Vecuronium.pdf
   

10. Sugammadex watch out for new side effects.pdf
    

11. Sugammadex.pdf
    

12. Sugammadex:Monitoring of Neuromuscular Blockade.pdf
    

13. The Right Dose of Succinylcholine.pdf
    

14. Time to desaturation after suxamethonium apnoea.pdf
    

15. To Reverse or Not To Reverse.pdf
    

16. Undetected residual neuromuscular block Edit.pdf

1. Pharmacokinetic Model for Target Controlled Infusion of Propofol.pdf
   

2. Principles of total intravenous anaesthesia.pdf
   

3. Quantifying Anesthetic Drug Interaction.pdf
   

4. Target controlled propofol and sufentanyl.pdf
   

5. Target-Controlled Infusion Not a One-Sized-Fits-All Answer to Drug Administration.pdf
   

6. The History of Target-Controlled Infusion.pdf
   

7. TIVA ASA03.pdf
   

1. Postop opioids versus tramadol.pdf
   

2. Remifentail in practice.pdf
   

3. Remifentanil Review.pdf
   

4. Remifentanil tolerance and hyperalgesia Review 2016.pdf
   

5. Tramadol – the MarmiteTM drug.pdf
   

6. Tramadol Review 2017.pdf

1. The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II).pdf
   

2. Uses of MAC edit.pdf
   

3. Volatile Agents Miller.pdf

1. Pharmacology of intravenous anaesthetic agents.pdf
   

2. Propofol and food allergy.pdf
   

3. Propofol Formulation Review.pdf
   

4. Propofol pro or anticonvulsant.pdf
   

5. Recent advances in IV anaesthesia Review.pdf
   

6. Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression.pdf
   

7. Slow Infusion of Low-dose Ketamine Reduces Bothersome Side Effects Compared to Intravenous Push.pdf
   

8. The ketamine story.pdf
   

9. The Reemergence of Ketamine for Treatment in Critically Ill Adults Review 2020.pdf